Progression of myocardial fibrosis is the major determinant of heart failure hospitalization in patients undergoing transcatheter aortic valve implantation.

Back

ESC2024 Premium Access

Progression of myocardial fibrosis is the major determinant of heart failure hospitalization in patients undergoing transcatheter aortic valve implantation.

Session: Unresolved questions in TAVI: stroke protection and left ventricular structure and function

Topic: Aortic Valve Intervention

Speaker: Doctor K. Yamaguchi (Suita, JP)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Kenta Yamaguchi

National Cerebral & Cardiovascular Center, Suita (Japan)

0 follower

8 more presentations in this session

Identification of new instances of white matter hyperintensities in patients following TAVI (from the CAPITA study)

Speaker: Doctor K. Hemelrijk (Amsterdam, NL)

Predisposing and precipitating factors of post-operative delirium after transfemoral TAVI

Speaker: Doctor K. Steinhaus (Goettingen, DE)

Objective functional improvement and vital prognosis after TAVR in patients with low-gradient aortic stenosis. Development of a predictive score.

Speaker: Doctor C. Garilleti Camara (Santander, ES)

Prognostic impact of left ventricular ejection fraction improvement after transcatheter aortic valve replacement

Speaker: Mr J. Reichl (Basel, CH)

Echocardiographic and clinical features of patients developing prosthesis-patient mismatch after TAVI: insights from an international multicenter registry.

Speaker: Doctor J. Rampone (Turin, IT)

Access the full session

Unresolved questions in TAVI: stroke protection and left ventricular structure and function

Speakers: Doctor K. Yamaguchi, Doctor K. Hemelrijk, Doctor K. Steinhaus, Doctor C. Garilleti Camara, Mr J. Reichl...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources